Halitosis Treatment Market Global Share, Trend Analysis and Forecast Report

Halitosis Treatment Market Report, By Indication (Gastrointestinal Disorders, Kidney Disorder, Liver Disorders, Respiratory Disorders and Systemic Disorders), Diagnosis (B- Galactosidase Activity Assay, BANA Test, Gas Chromatography and halimeter), Drug Treatment (Antacids, Antiseptics and Ranitidine) and Geography - Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : hc1823 | Publish Date : Upcoming | Industry : Healthcare | Geography : Global


Halitosis or bad breath is an offensive, unpleasant smell of the breath, independent of the cause. It can be caused by a variety of things, including diet, medication, poor oral hygiene, and diseases or conditions such as diabetes, GERD, lactose intolerance, gum disease, and more. The most commonly used anti-halitosis products are chewing gum, candies, and mouth rinse. However, it is known that these products only have a masking effect, and thus they are not able to influence the cause of bad breath. The global halitosis treatment market is estimated and forecasted in terms of revenue (USD million) generated by the global market.

Halitosis Treatment Market Outlook

The global halitosis treatment market has gained sustainable growth owing to rising geriatric population and increasing prevalence of chronic diseases. The market is further boosted by rising prevalence of periodontal diseases. Moreover, the market is expected to show robust growth during the forecast period due to surging initiatives by various government agencies and technological advancements. However, the global halitosis treatment market is hindered by lack of awareness about halitosis and its treatment.


Halitosis Treatment Market Segmental Overview

The report analyses the global halitosis treatment market based on indication, diagnosis, treatment and geography. 

Halitosis Treatment Market by Indication 

Based on indication, the global halitosis treatment market is segmented into gastrointestinal disorders, kidney disorder, liver disorders, respiratory disorders and systemic disorders. The respiratory segment is further segmented into sinusitis, tuberculosis, emphysema, pharyngitis, pneumonia, and others. The liver segment is sub-segmented into liver failure, gall bladder diseases, and others. Moreover, the gastrointestinal segment is sub-segmented into oesophageal reflux, stomach cancer, malabsorption, and pharyngitis. 

Halitosis Treatment Market by Diagnosis 

Based on diagnosis, the market is segmented into b- galactosidase activity assay, BANA test, gas chromatography, halimeter and other tests. The halimeter has become the premier instrument for chronic halitosis research, diagnosis, and therapy. The halimeter offers greatly enhanced patient outcomes in the treatment of oral malodor. It is also used to determine the source of the oral malodor, determine its severity, and monitor the progress of treatment. 

Halitosis Treatment Market by Drug Treatment 

Based on drug treatment, the global halitosis treatment market is categorized into antacids, antiseptics, ranitidine and other treatments (cetylpyridinium chloride and cimetidine). Among these, the antiseptics segment is anticipated to grow at the highest CAGR during the forecast period. 

Halitosis Treatment Market by Geography 

By geography, the global halitosis treatment market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world including Latin America, and Middle East & Africa. North America is estimated to account for the largest share in 2017, followed by Europe and Asia-Pacific. Factors such as rising prevalence of gum diseases and extensive use of oral care products such as toothpastes, mouth washes, mouth sprays, etc. are fuelling the growth of halitosis treatment in North America. Furthermore, Europe has been the second largest market for halitosis treatment. This market is majorly boosted by increase in awareness regarding halitosis and products available for its treatment. In addition to this, the Asia-Pacific region is expected to grow at a lucrative growth rate during the forecast period. Rising prevalence of chronic diseases such diabetes, respiratory diseases, kidney or liver failure with the increasing population are drivers of halitosis treatment market of APAC.

Halitosis Treatment Market Key Players            

Some of the key participants in the global halitosis treatment market are Colgate-Palmolive Company, All USA Partners LLC, Dr. Harold Katz, LLC, Rowpar Pharmaceuticals, Inc., Abbott Laboratories, AstraZeneca, Listerine etc. Most of the prominent companies are aiming at capturing the considerable market share through new product development and research & development at global level.

The global halitosis treatment market is segmented based on indication, diagnosis, treatment and geography. Based on indication, the global halitosis treatment market is segmented into gastrointestinal disorders, kidney disorder, liver disorders, respiratory disorders and systemic disorders. The respiratory segment is further segmented into sinusitis, tuberculosis, emphysema, pharyngitis, pneumonia, and others. The liver segment is sub-segmented into liver failure, gall bladder diseases, and others. Moreover, the gastrointestinal segment is sub-segmented into oesophageal reflux, stomach cancer, malabsorption, and pharyngitis. Based on diagnosis, the market is segmented into b- galactosidase activity assay, BANA test, gas chromatography, halimeter and other tests. The halimeter has become the premier instrument for chronic halitosis research, diagnosis, and therapy. The halimeter offers greatly enhanced patient outcomes in the treatment of oral malodor. It is also used to determine the source of the oral malodor, determine its severity, and monitor the progress of treatment. Based on drug treatment, the global halitosis treatment market is categorized into antacids, antiseptics, ranitidine and other treatments (cetylpyridinium chloride and cimetidine). Among these, the antiseptics segment is anticipated to grow at the highest CAGR during the forecast period. By geography, the global halitosis treatment market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world including Latin America, and Middle East & Africa. North America is estimated to account for the largest share in 2017, followed by Europe and Asia-Pacific. Factors such as rising prevalence of gum diseases and extensive use of oral care products such as toothpastes, mouth washes, mouth sprays, etc. are fuelling the growth of halitosis treatment in North America. 

Why to buy this report:

  • The report offers changing market dynamics in the halitosis treatment industry, presenting historical, current and projected market size in terms of value (USD million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of halitosis treatment, such as dental disorders market, dental devices market etc.
  • It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the halitosis treatment market performance
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of halitosis treatment market